Table 2 Enrolled sample characteristics (N = 100)
Alla | Patient Activation Measure Level 1–2 (n = 9) | Patient Activation Measure Level 3 (n = 30) | Patient Activation Measure Level 4 (n = 51) | |
|---|---|---|---|---|
N | 100 | 9 | 30 | 51 |
Age | ||||
Mean (SD) | 66 (12) | 72 (11) | 66 (11) | 67 (11) |
Median (IQR) | 67 (62–73) | 71 (67–75) | 68 (62–73) | 67 (62–75) |
Range | 28–96 | 57–96 | 28–84 | 34–87 |
Sex n (%) | ||||
Male | 48 (48) | 6 (67) | 15 (52) | 23 (46) |
Female | 52(52) | 3 (13) | 14 (48) | 27 (54) |
Race n (%) | ||||
Black or African American | 3 (3.0) | 0 (0) | 0 (0) | 2 (3.9) |
American Indian or Alaska Native | 1(1) | 0 (0) | 1 (3.3) | 0 (0) |
Other | 6 (6.0) | 0 (0) | 1 (3.3) | 4 (7.8) |
White | 83 (83.0) | 9 (100.0) | 26 (92.6) | 42 (82.4) |
Ethnicity | ||||
Hispanic or Latino | 15(15.)) | 0 (0) | 2 (7.4) | 2 (4.3) |
Not Hispanic or Latino (%) | 85(85.0) | 9 (100) | 25 (92.6) | 45 (95.7) |
Charleston Comorbidities index (unweighted) | ||||
Mean (SD) | 2.53 (1.81) | 2.33 (1.66) | 2.52 (1.70) | 2.48 (1.76) |